Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-04

Clinical Trial Update: Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta

View source ↗

Summary

A completed study from Massachusetts General Hospital analyzed family risk of substance use in youth with attention-deficit/hyperactivity disorder treated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: ADHD, Smoking | Status: COMPLETED